Correlation Between Knight Therapeutics and Dexterra

Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and Dexterra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and Dexterra into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Knight Therapeutics and Dexterra Group, you can compare the effects of market volatilities on Knight Therapeutics and Dexterra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of Dexterra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and Dexterra.

Diversification Opportunities for Knight Therapeutics and Dexterra

-0.41

Correlation Coefficient

Knight Therapeutics  Dexterra

Very good diversification

The 3 months correlation between Knight and Dexterra is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and Dexterra Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dexterra Group and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with Dexterra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dexterra Group has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and Dexterra go up and down completely randomly.

Pair Corralation between Knight Therapeutics and Dexterra

Assuming the 90 days trading horizon Knight Therapeutics is expected to generate 40.4 times less return on investment than Dexterra. In addition to that, Knight Therapeutics is 1.49 times more volatile than Dexterra Group. It trades about 0.0 of its total potential returns per unit of risk. Dexterra Group is currently generating about 0.28 per unit of volatility. If you would invest  631.00  in Dexterra Group on October 24, 2024 and sell it today you would earn a total of  147.00  from holding Dexterra Group or generate 23.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Knight Therapeutics  vs.  Dexterra Group

Knight Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Knight Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Dexterra Group

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Dexterra Group are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Dexterra displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Knight Therapeutics and Dexterra

The main advantage of trading using opposite Knight Therapeutics and Dexterra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, Dexterra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dexterra will offset losses from the drop in Dexterra's long position.

The idea behind Knight Therapeutics and Dexterra Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.